Glomerulonephritis in populations

Clinical Nephrology

Volumn 74, Issue SUPPL.1, 2010, Pages

  Barsoum, R S ^a  

^a Cairo Kidney Center   (Egypt)

Author keywords

Developing world; Fsgs; Racial susceptibility; Secondary glomerulonephritis; Tropical glomerulonephritis

Indexed keywords

EID: 84876265012     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Adhikari M, Bhimma R, Coovadia HM. Focal segmental glomerulosclerosis in children from KwaZulu/Natal, South Africa. Clin Nephrol. 2001; 55: 16-24.
2. al-Rasheed SA, al-Mugeiren MM, al-Salloum AA, al-Sohaibani MO. Childhood renal diseases in Saudi Arabia. A clinicopathological study of 167 cases. Int Urol Nephrol. 1996; 28: 607-613.
3. Andreoli SP. Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children. Adv Ren Replace Ther. 2004; 11: 105-109.
4. Barsoum RS, Francis M. Spectrum of glomerulonephritis in Egypt. Saudi J Kidney Dis Transplantation. 2000; 11: 1-9.
5. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006; 354: 997-999.
6. Barsoum RS. Hepatitis C virus: from entry to renal injury. Nephrol Dial Transplant. 2007; 22: 1840-1848.
7. Barsoum RS. The changing face of schistosomal glomerulopathy. Kidney Int 2004; 66: 2472-2484.
8. Barsoum RS. Overview: end-stage renal disease in the developing world. Artif Organs. 2002; 26: 737-746.
9. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004; 24: 198-211.
10. Cheong I, Kong N, Segasothy M, Moras Z, Menon P, Suleiman AB. IgA nephropathy in Malaysia. Southeast Asian J Trop Med Public Health. 1991; 22: 120-122.
11. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. The impact of HIV on chronic kidney disease outcomes. Kidney Int. 2007; 72: 1380-1387.
12. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006; 15: 308-318.
13. Hurtado A, Johnson RJ. Hygiene hypothesis and prevalence of glomerulonephritis. Kidney Int. 2005; 68: 62-67.
14. Stewart JH, McCredie MR, McDonald S. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in indigenous Australians. Nephrol Dial Transplant. 2004; 19: 678-685.
15. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008; 40: 1175-1184.
16. Lee DY, Kim W, Kang SK, Koh GY, Park SK. Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis. Nephron. 1997; 77: 471-473.
17. Li GS, Zhang H, Lv JC, Shen Y, Wang HY. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007; 71: 379-381.
18. Li L, Liu Z. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004; 66: 920-923.
19. Li PK, Poon AS, Lai KN. Molecular genetics of MHC class II alleles in Chinese patients with IgA nephropathy. Kidney Int. 1994; 46: 185-190.
20. Lopes AA, Martinelli RP, Silveira MA, Rocha H. Racial differences between patients with focal segmental glomerulosclerosis and membranoproliferative glomerulonephritis from the State of Bahia. Rev Assoc Med Bras. 1999; 45: 115-120.
21. Malafronte P, Mastroianni-Kirsztajn G, Betônico GN, Romão JE Jr, Alves MA, Carvalho MF, Viera Neto OM, Cadaval RA, Bérgamo RR, Woronik V, Sens YA, Marrocos MS, Barros R. Paulista Registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant. 2006; 21: 3098-3105.
22. Mazzarolo Cruz HM, Cruz J, Silva ALJr, Saldanha LB, de Oliveira Penna D. Prevalence of adult primary glomerular diseases: retrospective analysis of 206 kidney biopsies (1990 - 1993). Rev Hosp Clin Fac Med Sao Paulo. 1996; 51: 3-6.
23. McLigeyo SO. Gromerular diseases in Kenya - another look at diseases characterised by nephritic proteinura. Afr J Health Sci. 1994; 1: 185-190.
24. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962; 14: 353-362.
25. Olsen ML, Goldstein R, Arnett FC, Duvic M, Pollack M, Reveille JD. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics. 1989; 30: 27-33.
26. Shah VO, Scavini M, Stidley C, Tentori F, Welty T, Maccluer JW. Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: The Zuni Kidney Project. JAmSoc Nephrol. 2003; 14: 1320-1329.
27. Xu G, He Q, Shou Z, Wang H, Zhang X, Wang Y, Chen Y, Chen J. NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese. J Clin Lab Anal. 2007; 21: 298-302.